Comparison of cardiovascular risk factors between prehypertension and hypertension in a mongolian population, Inner Mongolia, China

Circulation Journal

Volumn 72, Issue 10, 2008, Pages 1666-1673

  Li, Hongmei ^a   Xu, Tan ^a   Tong, Weijun ^a   Liu, Yanbin ^a   Zhao, Li ^b   Zhang, Yonghong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Tongliao Center for Disease Prevention and Control   (China)

Author keywords

Hypertension; Prehypertension; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHINA; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PHYSICAL EXAMINATION; PREHYPERTENSION; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONGOLIA; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 52649182621     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0138     Document Type: Article

References (36)

1. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
2. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36: 1859-1863.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
4. The National Committee on Prevention and Treatment of Hypertension in China. China Guidelines on Prevention and Management of High Blood Pressure (revised edition 2005 [R]. Beijing: People's Medical Publishing House, 2005.
5. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1990 - 2000. Arch Intern Med 2004; 164: 2113-2118.
6. Liszka HA, Mainous AG, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005; 3: 294-299.
7. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119: 133-141.
8. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001; 358: 1682-1686.
9. Winegarden CR. From "prehypertension" to hypertension? Additional evidence. Ann Epidemiol 2005; 15: 720-725.
10. Suri MF, Qureshi AI. Prehypertension as a risk factor for cardiovascular diseases. J Cardiovasc Nursing 2006; 21: 478-482.
11. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu LL, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115: 855-860.
12. Ueshima H, Zhang X, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000; 14: 765-769.
13. Ying C, Liu Y, Zhang Y, Liu L, Tong W, Li Y. Relationship between essential hypertension and related factors in Mongolian population. Chin J Public Health 2004; 20: 1487-1488.
14. Cooperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 2002; 23: 5-10.
15. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. New York: John Wiley & Sons; 2000.
16. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23: 1355-1360.
17. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med 2004; 164: 2126-2134.
18. Aekplakorn W, Abbott-Klafter J, Khonputsa P, Tatsanavivat P, Chongsuvivatwong V, Charyalertsak S, et al. Prevalence and management of prehypertension and hypertension by geographic regions of Thailand: The Third National Health Examination Survey, 2004. J Hypertens 2008; 26: 191-198.
19. Sun ZQ, Zheng LQ, Wei YD, Li J, Zhang XZ, Zhang XQ, et al. The prevalence of prehypertension and hypertension among rural adults in Liaoning Province of China. Clin Cardiol 2007; 30: 183-187.
20. Sun J, Zhao D, Wang W, Liu J, Wu C, Wang W. The change of blood pressure during ten years (1992-2002) in 2740 subjects in Beijing. Chin J Hypertens 2005; 13: 115-119.
21. Zhu H, Yan W, Ge D, Treiber FA, Harshfield GA, Kapuku G, et al. Cardiovascular characteristics in American youth with prehypertension. Am J Hypertens 2007; 20: 1051-1057.
22. Agyemang C, Van Valkengoed I, van den BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch in Amsterdam, the Netherlands: The SUNSET study. Eur J Cardiovasc Prev Rehabil 2007; 14: 775-781.
23. Israeli E, Schochat T, Korzets Z, Tekes-Manova D, Bernheim J, Golan E. Prehypertension and obesity in adolescents: A population study. Am J Hypertens 2006; 19: 708-712.
24. Pang W, Sun Z, Zheng L, Li J, Zhang X, Liu S, et al. Body mass index and the prevalence of prehypertension and hypertension in a Chinese rural population. Intern Med 2008; 47: 893-897.
25. Sun ZQ, Zheng LQ, Wei YD, Li J, Zhang XZ, Zhang XG, et al. Prevalence and risk factors of the rural adult people prehypertension status in Liaoning Province of China. Circ J 2007; 71: 550-553.
26. Wong ND. Metabolic syndrome cardiovascular risk assessment and management. Am J Cardiovasc Drugs 2007; 7: 259-272.
27. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertension 2004; 6: 562-568.
28. Kim BJ, Lee HJ, Sung KC, Kim BS, Kang JH, Lee MH, et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007; 71: 1283-1287.
29. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: The Strong Heart Study. Hypertension 2006; 47: 410-414.
30. Smith SC. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 2007; 120: S3-S11.
31. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 3: 159-164.
32. Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, et al. DASH-Sodium Collaborative Research Group: Effect of the dietary approaches to stop hypertension (DASH) diet and reduced sodium intake on blood pressure control. J Clin Hypertens 2004; 6: 373-381.
33. Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: Epidemiologic findings. Am Heart J 1986; 111: 932-940.
34. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: Evidence from the health survey for England. Hypertension 2001; 37: 187-193.
35. Lee DH, Ha MH, Kim J, David R, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: A 4-year follow up study. Hypertension 2001; 37: 194-198.
36. Narnkiewicz K, Kjeldsen SE, Hedner T. Is smoking a causative factor of hypertension? Blood Press 2005; 14: 69-71.